A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.

Clinical trial NCT05303402 · COMPLETED

Trial details

NCT number: NCT05303402
Sponsor: Hipra Scientific, S.L.U
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SARS CoV 2 Infection

Start date: 2022-05-12
Primary completion: 2023-07-29
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.